Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALACARTE: Shared decision-making in uncomplicated appendicitis
2025-520783-17-01Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of amoxicillin + clavulanate in acute appendicitis (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Jul 2026; status: authorised.
02
Drugs
amoxicillin + clavulanate
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on 2025-520783-17-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520783-17-01.